Countdown Appoints Julie Teer CEO
Analysis based on 6 articles · First reported Aug 18, 2026 · Last updated Aug 18, 2026
The appointment is unlikely to have a direct impact on public markets as Countdown is a nonprofit. However, it signals organizational growth in the mitochondrial research field, which may attract attention from investors in longevity and cellular health sectors.
Countdown, a global nonprofit focused on accelerating mitochondrial science and medicine, announced on August 18, 2026, the appointment of Julie Teer as Chief Executive Officer, effective September 1, 2026. Teer, a healthcare and nonprofit executive, will lead strategy, fundraising, partnerships, and operations. She previously served as Senior Vice President of Wellstar Health System and President of the Wellstar Foundation, and held leadership roles at Boys & Girls Clubs of America and Susan G. Komen. Founder Solomon will continue as President. The appointment reflects Countdown's growth and ambition to bring mitochondrial health into mainstream medicine.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard